J&J Settles Risperdal Lawsuit on Opening Day of Trial

Johnson & Johnson settled a lawsuit on the first day of a trial over claims its antipsychotic drug Risperdal caused a male plaintiff to grow breast tissue, one of his lawyers told a state judge in Philadelphia.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.